ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden
· Delayed Price · Currency is SEK 23.50
+0.35 (1.51%)
May 30, 2025, 5:29 PM CET
STO:EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 2.96M SEK in the quarter ending March 31, 2025, with 89.79% growth. This brings the company's revenue in the last twelve months to 9.22M, up 18.76% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.
Revenue (ttm)
9.22M
Revenue Growth
+18.76%
P/S Ratio
6.77
Revenue / Employee
512.44K
Employees
18
Market Cap
62.47M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| Vimian Group AB | 4.24B |
| AddLife AB | 10.42B |